Oppenheimer & Co’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$996K Buy
182,743
+42,186
+30% +$237K 0.01% 860
2025
Q4
$984K Buy
140,557
+8,722
+7% +$68.3K 0.01% 810
2025
Q3
$1.02M Buy
131,835
+14,204
+12% +$111K 0.01% 877
2025
Q2
$1.02M Buy
117,631
+18,300
+18% +$133K 0.01% 839
2025
Q1
$791K Buy
99,331
+6,480
+7% +$65.6K 0.01% 902
2024
Q4
$844K Buy
92,851
+6,300
+7% +$60.8K 0.01% 865
2024
Q3
$795K Buy
86,551
+50,026
+137% +$414K 0.01% 865
2024
Q2
$357K Buy
36,525
+12,100
+50% +$148K 0.01% 1123
2024
Q1
$369K Buy
24,425
+12,561
+106% +$228K 0.01% 1098
2023
Q4
$256K Buy
+11,864
New +$219K ﹤0.01% 1199
2022
Q3
Sell
-6,165
Closed -$205K 1460
2022
Q2
$205K Sell
6,165
-8,615
-58% -$366K ﹤0.01% 1262
2022
Q1
$1.07M Sell
14,780
-7,224
-33% -$520K 0.02% 723
2021
Q4
$2.02M Buy
22,004
+392
+2% +$46.9K 0.04% 508
2021
Q3
$2.74M Buy
21,612
+1,828
+9% +$266K 0.05% 407
2021
Q2
$3.29M Buy
19,784
+1,870
+10% +$303K 0.06% 368
2021
Q1
$3.26M Sell
17,914
-98
-0.5% -$22.7K 0.07% 346
2020
Q4
$3.6M Buy
18,012
+3,505
+24% +$713K 0.08% 299
2020
Q3
$3.18M Buy
14,507
+3,458
+31% +$732K 0.08% 283
2020
Q2
$2.11M Buy
11,049
+257
+2% +$45K 0.05% 371
2020
Q1
$1.67M Sell
10,792
-4,389
-29% -$511K 0.05% 390
2019
Q4
$1.27M Buy
15,181
+2,243
+17% +$171K 0.03% 545
2019
Q3
$876K Sell
12,938
-12,353
-49% -$813K 0.02% 631
2019
Q2
$1.68M Buy
25,291
+17,377
+220% +$1.01M 0.05% 443
2019
Q1
$440K Sell
7,914
-321
-4% -$19.6K 0.01% 876
2018
Q4
$408K Sell
8,235
-71,037
-90% -$4.35M 0.01% 817
2018
Q3
$6.84M Buy
79,272
+67,663
+583% +$4.82M 0.17% 129
2018
Q2
$674K Buy
11,609
+3,642
+46% +$178K 0.02% 750
2018
Q1
$321K Buy
7,967
+277
+4% +$10.5K 0.01% 1022
2017
Q4
$268K Sell
7,690
-214
-3% -$7.11K 0.01% 1106
2017
Q3
$262K Buy
+7,904
New +$259K 0.01% 1086

Other funds holding TDOC